Withheld: Real-World Infant Deaths from RSV Antibody Shot
As ACIP deliberated without access to full trial data, an even more alarming pattern was already unfolding in the real world. Now, analysis of the FDA’s FAERS database reveals 37 infant deaths out of just 991 reports—a fatality signal nearly twice that of other routine vaccines. Why was this not disclosed? The warning sign was […]
ACIP Majority Ignores Risks and Recommends Infants Get Merck’s RSV Monoclonal Antibody
On June 25, 2025, the majority of members of the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) ignored risk warnings and voted for a recommendation that infants be given Merck & Co.’s monoclonal antibody, clesrovimab, marketed as Enflonsia. The committee advised using Enflonsia to prevent Respiratory Syncytial Virus […]